Survival Benefit of Stereotactic Radiosurgery for Patients with Malignant Glial Neoplasms
- 1 October 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 41 (4), 776-785
- https://doi.org/10.1097/00006123-199710000-00004
Abstract
OBJECTIVE. During an 8-year interval, we evaluated the survival benefit of stereotactic radiosurgery performed in 64 patients with glioblastomas multifKeywords
This publication has 29 references indexed in Scilit:
- Radiation response and survival time in patients with glioblastoma multiformeJournal of Neurosurgery, 1996
- Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma TrialsJNCI Journal of the National Cancer Institute, 1993
- Resection, biopsy, and survival in malignant glial neoplasmsJournal of Neurosurgery, 1993
- Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implantsInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Selection bias, survival, and brachytherapy for gliomaJournal of Neurosurgery, 1992
- Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant gliomaInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Regrowth Patterns of Glioblastoma Multiforme Related to Planning of Interstitial Brachytherapy Radiation FieldsNeurosurgery, 1988
- Survival after Stereotactic Biopsy of Malignant GliomasNeurosurgery, 1988
- Reoperation in the Treatment of Recurrent Intracranial Malignant GliomasNeurosurgery, 1987
- A Confidence Interval for the Median Survival TimeBiometrics, 1982